1. An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results. (16th October 2015) Authors: Doody, Rachelle S.; D'Amico, Stephen; Cutler, Andrew J.; Davis, Charles S.; Shin, Paul; Ledon, Fred; Yonan, Charles; Siffert, João Journal: CNS spectrums Issue: Volume 21:Number 6(2016:Dec.) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. (1st January 2021) Authors: Ganz, Michael L.; Chavan, Ameya; Dhanda, Rahul; Serbin, Michael; Yonan, Charles Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. Issue 1 (December 2016) Authors: Hammond, Flora; Alexander, David; Cutler, Andrew; D'Amico, Stephen; Doody, Rachelle; Sauve, William; Zorowitz, Richard; Davis, Charles; Shin, Paul; Ledon, Fred; Yonan, Charles; Formella, Andrea; Siffert, Joao Journal: BMC neurology Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113. (1st January 2021) Authors: Serbin, Michael; Yonan, Charles; Ganz, Michael L. Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O4‐09‐06: Dextromethorphan/quinidine for treatment of pseudobulbar affect in patients with dementia: Treatment effects by concomitant antidepressant use in a 12‐week open‐label trial (PRISM II). (1st July 2015) Authors: Doody, Rachelle S.; D'Amico, Stephen; Cutler, Andrew J.; Shin, Paul; Ledon, Fred; Yonan, Charles; Siffert, Joao Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7S:Part 6 Page Start: P292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1‐300: Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Comparison of patient‐reported ratings to those of caregiver proxies in a 12‐week open‐label trial (PRISM II). (1st July 2015) Authors: Doody, Rachelle S.; Cutler, Andrew J.; D′Amico, Stephen; Shin, Paul; Ledon, Fred; Yonan, Charles; Siffert, Joao Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 10 Page Start: P471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P3‐290: Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Examination of cns‐ls outcomes in a 12‐week open‐label trial (PRISM II). (1st July 2015) Authors: Doody, Rachelle S.; D'Amico, Stephen; Cutler, Andrew J.; Shin, Paul; Ledon, Fred; Yonan, Charles; Siffert, Joao Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 16 Page Start: P743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P3–288: A study to assess the safety, tolerability and effectiveness of NUEDEXTA (dextromethorphan 20 mg/quinidine 10 mg) in the treatment of pseudobulbar affect (PBA) [PRISM‐II]. (1st July 2013) Authors: Doody, Rachelle; Cutler, Andrew; D'Amico, Stephen; Zorowitz, Richard; Alexander, David; Hammond, Flora; Sauve, William; Yonan, Charles Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 16 Page Start: P662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P4‐336: PREVALENCE AND CORRELATES OF PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN NURSING HOME RESIDENTS. (1st July 2014) Authors: Yonan, Charles; Foley, Kevin; Konetzka, R. Tamara Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 16 Page Start: P911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P4‐341: QUANTIFYING THE IMPACT OF PSEUDOBULBAR AFFECT (PBA) ON HEALTH‐RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH ALZHEIMER'S DISEASE TREATED WITH NUEDEXTA OR CONVENTIONAL MEDICATION. (1st July 2014) Authors: Badhan, Anita; Mealing, Stuart; Kiff, Chris; Yonan, Charles; Baculea, Simona; Singh, Moushmi Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 16 Page Start: P913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗